Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

Hermanson DJ, Gamble-George JC, Marnett LJ, Patel S
Trends Pharmacol Sci. 2014 35 (7): 358-67

PMID: 24845457 · PMCID: PMC4074568 · DOI:10.1016/j.tips.2014.04.006

MeSH Terms (7)

Animals Cannabinoids Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Humans Signal Transduction Substrate Specificity

Connections (2)

This publication is referenced by other Labnodes entities:

Links